Health Care & Life Sciences » Biotechnology | PanGen Biotech Inc.

PanGen Biotech Inc.

PanGen Biotech Inc.
Stock Exchange Korea Exchange
EPS
KRW665
Market Cap
KRW160.54 B
Shares Outstanding
9.64 M
Public Float
6.05 M

Profile

Address
4/F, YeongtongInnoplex II
Suwon GY 16675
Korea, Republic Of
Employees -
Website http://www.pangen.com
Updated 09/14/2018
PanGen Biotech, Inc. engages in the development of biopharmaceutical products. Its products include biosimilar erythropoietin, factor VIII and biosimilar G-CSF. The company was founded on January 29, 2010 and is headquartered in Suwon, South Korea.

Financials

View All

Young-Boo Kim
Co-Chief Executive Officer & Director
Jae-Seung Yoon
Co-Chief Executive Officer & Director